{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:06:28Z","timestamp":1778522788026,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejim.2021.10.005","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:57:25Z","timestamp":1634605045000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Risk factors for community-onset pneumonia caused by drug-resistant pathogens: A prospective cohort study"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5391-5883","authenticated-orcid":false,"given":"J. Vasco","family":"Barreto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia Camila","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2451-4260","authenticated-orcid":false,"given":"Teresa","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2021.10.005_bib0001","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections - full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.ejim.2021.10.005_bib0002","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"issue":"Supplement_2","key":"10.1016\/j.ejim.2021.10.005_bib0003","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious diseases society of America\/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2021.10.005_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.ejim.2021.10.005_bib0005","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American thoracic society and infectious diseases society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2021.10.005_bib0006","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Infectious diseases society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2021.10.005_bib0007","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1183\/09031936.01.00204401","article-title":"A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia","volume":"18","author":"Lim","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2021.10.005_bib0008","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Healthcare- associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2021.10.005_bib0009","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cid\/cit734","article-title":"Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis","volume":"58","author":"Chalmers","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ejim.2021.10.005_bib0010","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"6","key":"10.1016\/j.ejim.2021.10.005_bib0011","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/acem.12672","article-title":"Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia","volume":"22","author":"Self","year":"2015","journal-title":"Academic emergency medicine\u00a0: official journal of the Society for Academic Emergency Medicine"},{"key":"10.1016\/j.ejim.2021.10.005_bib0012","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1128\/AAC.03071-15","article-title":"Derivation and multicenter validation of the drug resistance in pneumonia clinical prediction score","volume":"60","author":"Webb","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ejim.2021.10.005_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119528","article-title":"Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia","volume":"10","author":"Falcone","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejim.2021.10.005_bib0014","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/cid\/cit571","article-title":"A new strategy for healthcare-associated pneumonia: a 2- year prospective multicenter cohort study using risk factors for multidrug resistant pathogens to select initial empiric therapy","volume":"57","author":"Maruyama","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2021.10.005_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/cir813","article-title":"Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department","volume":"54","author":"Shorr","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2021.10.005_bib0016","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cir840","article-title":"Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia","volume":"54","author":"Aliberti","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2021.10.005_bib0017","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201301-0079OC","article-title":"Risk factors for drug-resistant pathogens in community- acquired and healthcare-associated pneumonia","volume":"188","author":"Shindo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2021.10.005_bib0018","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1513\/AnnalsATS.201407-305OC","article-title":"Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia","volume":"12","author":"Prina","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.ejim.2021.10.005_bib0019","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1513\/AnnalsATS.201501-002ED","article-title":"Health care-associated pneumonia is mostly dead. Long live the acronym PES?","volume":"12","author":"Dean","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.ejim.2021.10.005_bib0020","first-page":"435","article-title":"Recomenda\u00e7\u00f5es de abordagem diagn\u00f3stica e terap\u00eautica da pneumonia da comunidade em adultos imunocompetentes","volume":"IX","author":"Froes","year":"2003","journal-title":"Rev Port Pneumol"},{"key":"10.1016\/j.ejim.2021.10.005_bib0021","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0873-2159(15)30360-3","article-title":"Consensus document on nosocomial pneumonia","volume":"13","author":"Froes","year":"2007","journal-title":"Rev Port Pneumol"},{"key":"10.1016\/j.ejim.2021.10.005_bib0022","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ejim.2021.10.005_bib0023","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2021.10.005_bib0024","series-title":"Nomenclature and criteria for diagnosis of diseases of the heart and great vessels","first-page":"253","year":"1994"},{"issue":"11","key":"10.1016\/j.ejim.2021.10.005_bib0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Improving global outcomes chronic kidney disease guideline development work group members. evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.ejim.2021.10.005_bib0026","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.ejim.2021.10.005_bib0027","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"1","key":"10.1016\/j.ejim.2021.10.005_bib0028","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/geront\/10.1_Part_1.20","article-title":"Progress in the development of the index of ADL","volume":"10","author":"Katz","year":"1970","journal-title":"Gerontologist"},{"key":"10.1016\/j.ejim.2021.10.005_bib0029","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1128\/AAC.02582-14","article-title":"Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia","volume":"58","author":"Gross","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"51","key":"10.1016\/j.ejim.2021.10.005_bib0030","doi-asserted-by":"crossref","first-page":"12896","DOI":"10.1073\/pnas.1721095115","article-title":"Impact of existing vaccines in reducing antibiotic resistance: primary and secondary effects","volume":"115","author":"Klugman","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2021.10.005_bib0031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/resp.12651","article-title":"Predictors of pseudomonas and methicillin-resistant staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia","volume":"21","author":"Metersky","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.ejim.2021.10.005_bib0032","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01190-2017","article-title":"Burden and risk factors for pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients","volume":"52","author":"Restrepo","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2021.10.005_bib0033","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S1473-3099(16)30267-5","article-title":"GLIMP Investigators. Global initiative for methicillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study","volume":"16","author":"Aliberti","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ejim.2021.10.005_bib0034","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1473-3099(15)00417-X","article-title":"Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for methicillin-resistant Staphylococcus aureus: a mathematical modelling study","volume":"16","author":"Robotham","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.ejim.2021.10.005_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159667","article-title":"Cost analysis of universal screening vs. risk factor-based screening for methicillin-resistant staphylococcus aureus (MRSA)","volume":"11","author":"Roth","year":"2016","journal-title":"PLoS ONE"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521003356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521003356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:35:57Z","timestamp":1760607357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620521003356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":35,"alternative-id":["S0953620521003356"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2021.10.005","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for community-onset pneumonia caused by drug-resistant pathogens: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2021.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}